BioCardia Inc (BCDA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

125 SHOREWAY ROAD SAN CARLOS, CA 94070

BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and respiratory disease. CardiAMP autologous and Neurokinin-1 Receptor Positive allogenic cell therapies are the Company's biotherapeutic platforms in clinical development. The Company's products include the Helix Biotherapeutic Delivery System and its steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix system and clinical support for their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, and acute myocardial infarction.

Data as of 2021-08-02 08:17:21 -0400
Market Cap55.752 Million Shares Outstanding16.793 Million Avg 30-day Volume50.478 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.03 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.92266 52-week High/Low8.6 / 1.91 Next Earnings Date Price to Cash FLow (P/CF) -16.6152
Data provided by IEX Cloud
View SEC Filings from BCDA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) 0 (0.0%)
Funds Holding: 21 18 16.67% 7 (0.41%) 4 (0.23%) 75.0%
13F shares: 3.118 Million 1.722 Million 81.03% 771.798 Thousand 270.125 Thousand 185.72%
% Ownership 25.0858 11.9045 110.73% 6.2098 1.8671 232.59%
New Positions: 5 9 -44.44% 3 3 0.0%
Increased Positions 8 4 100.0% 3 1 200.0%
Closed Positions 2 1 100.0%
Reduced Positions 3 1 200.0%
Total Calls
Total Puts 96.574 Thousand 35.4 Thousand
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BCDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCDA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STERTZER SIMON H

  • Director
22,642 2021-06-15 4

KRASNO RICHARD M

  • Director
12,434 2021-06-15 4

MOYES JAY M

  • Director
16,355 2021-06-15 4

ALLEN JIM L.

  • Director
12,434 2021-06-15 4

BLANK ANDREW SCOTT

  • Director
12,434 2021-06-15 4

ZSEBO KRISZTINA M

  • Director
12,434 2021-06-15 4

ALTMAN PETER PRESIDENT AND CEO

  • Officer
  • Director
229,409 2021-06-10 5

MCCLUNG DAVID CHIEF FINANCIAL OFFICER

  • Officer
46,805 2021-06-10 2

GILLIS EDWARD M SENIOR VICE PRESIDENT, DEVICES

  • Officer
6,082 2021-06-10 2

PFENNIGER RICHARD C JR

  • Director
51,970 2020-12-31 2

DUCKERS ERIC CHIEF MEDICAL OFFICER

  • Officer
12,088 2020-11-02 1

FERNANDEZ FERNANDO L

  • Director
40,644 2020-09-30 1

PESTA PHIL VICE PRESIDENT OF OPERATIONS

  • Officer
11,867 2020-06-30 0

QUERTERMOUS THOMAS

  • Director
15,681 2019-07-26 0

TESSLER ALLAN R

  • Director
109,534 2019-07-05 0

FROST PHILLIP MD ET AL

FROST GAMMA INVESTMENTS TRUST

  • 10% Owner
12,875,318 2018-12-24 0

STERTZER KIMBERLY

  • 10% Owner
6,920,425 2018-12-24 0

STERTZER FAMILY TRUST

  • 10% Owner
4,278,274 2018-12-24 0

ALLEN RICHARD T VICE PRESIDENT OF QUALITY

  • Officer
0 2018-02-01 0

RUBIN STEVEN D INTERIM CEO AND INTERIM CFO

  • Officer
  • Director
302,822 2016-08-11 0

UPPALURI SUBBARAO V

  • Director
471,592 2016-08-11 0

LIU STEPHEN H

  • Director
2,875,000 2016-08-11 0

MORGAN THOMAS H.

  • Director
40,419 2016-05-10 0

BROOKS ANDREW A CEO

  • Officer
  • Director
  • 10% Owner
0 2016-05-10 0

RICHARDS RONALD N.

  • Director
0 2016-05-10 0

BROOKS JONATHAN

  • Director
  • 10% Owner
91,000 2016-05-10 0

KVITNITSKY MIKHAIL

  • 10% Owner
No longer subject to file 2011-07-01 0

LOGGIA JOSEPH

  • Director
0 2008-09-19 0

HALPRYN GLENN L CEO

  • Officer
  • Director
533,312 2008-08-29 0

GLAUSER STEVEN JERRY

  • 10% Owner
No longer subject to file 2008-08-29 0

ROMINE DERRICK CFO OF CARDO MEDICAL, LLC

  • Officer
667,941 2008-08-29 0

WEISBERG ALAN JAY CFO, DIRECTOR

  • Officer
  • Director
502,401 2007-11-02 0

LOCKSHIN CURTIS

  • Director
90,960 2007-11-02 0

SILVER NOAH M VICE PRES., SECY., TREASURER

  • Officer
  • Director
1,679,604 2007-11-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MOYES JAY M - Director

2021-06-15 20:47:50 -0400 2021-06-15 A 12,434 a 16,355 direct

KRASNO RICHARD M - Director

2021-06-15 20:48:59 -0400 2021-06-15 A 12,434 a 12,434 direct

ALLEN JIM L. - Director

2021-06-15 20:48:11 -0400 2021-06-15 A 12,434 a 12,434 direct

STERTZER SIMON H - Director

2021-06-15 20:49:33 -0400 2021-06-15 A 12,434 a 22,642 direct

BLANK ANDREW SCOTT - Director

2021-06-15 20:48:37 -0400 2021-06-15 A 12,434 a 12,434 direct

ZSEBO KRISZTINA M - Director

2021-06-15 20:49:59 -0400 2021-06-15 A 12,434 a 12,434 direct

ALTMAN PETER - Director - Officer PRESIDENT AND CEO

2021-06-11 18:16:59 -0400 2021-06-10 F 11,572 $4.35 d 229,409 direct -0.8949 8.7248 -27.0694 11.6331 3 -27.0694 31

GILLIS EDWARD M - Officer SENIOR VICE PRESIDENT, DEVICES

2021-06-11 18:15:37 -0400 2021-06-10 F 9,953 $4.35 d 6,082 direct -0.8949 8.7248 -27.0694 11.6331 3 -27.0694 31

MCCLUNG DAVID - Officer CHIEF FINANCIAL OFFICER

2021-06-11 18:16:29 -0400 2021-06-10 F 7,274 $4.35 d 46,805 direct -0.8949 8.7248 -27.0694 11.6331 3 -27.0694 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOCARDIA INC BCDA 2021-08-05 22:15:04 UTC -4.9567 5.0367 150000
BIOCARDIA INC BCDA 2021-08-05 21:45:03 UTC -4.9316 5.0116 150000
BIOCARDIA INC BCDA 2021-08-05 21:15:03 UTC -4.9316 5.0116 150000
BIOCARDIA INC BCDA 2021-08-05 20:45:03 UTC -4.872 4.952 150000
BIOCARDIA INC BCDA 2021-08-05 20:15:04 UTC -4.872 4.952 150000
BIOCARDIA INC BCDA 2021-08-05 19:45:04 UTC -4.872 4.952 150000
BIOCARDIA INC BCDA 2021-08-05 19:15:03 UTC -4.872 4.952 150000
BIOCARDIA INC BCDA 2021-08-05 18:45:03 UTC -5.0185 5.0985 150000
BIOCARDIA INC BCDA 2021-08-05 18:15:03 UTC -5.0185 5.0985 150000
BIOCARDIA INC BCDA 2021-08-05 17:45:03 UTC -5.0185 5.0985 150000
BIOCARDIA INC BCDA 2021-08-05 17:15:03 UTC -5.0185 5.0985 150000
BIOCARDIA INC BCDA 2021-08-05 16:45:02 UTC -4.9178 4.9978 150000
BIOCARDIA INC BCDA 2021-08-05 16:15:03 UTC -4.9178 4.9978 150000
BIOCARDIA INC BCDA 2021-08-05 15:45:03 UTC -4.9178 4.9978 150000
BIOCARDIA INC BCDA 2021-08-05 15:15:02 UTC -4.9178 4.9978 150000
BIOCARDIA INC BCDA 2021-08-05 14:45:02 UTC -4.8911 4.9711 150000
BIOCARDIA INC BCDA 2021-08-05 14:15:04 UTC -4.8911 4.9711 150000
BIOCARDIA INC BCDA 2021-08-05 13:45:04 UTC -4.8911 4.9711 150000
BIOCARDIA INC BCDA 2021-08-05 13:15:03 UTC -4.8911 4.9711 150000
BIOCARDIA INC BCDA 2021-08-05 12:45:03 UTC -4.8911 4.9711 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BCDA -600.0 shares, $-2604.0 2021-03-31 N-PORT

Elevate your investments